AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Sorrento Therapeutics, Inc.

$0 -$0.00 (-87.30%)
OTC · 14 Sep 2026 19:42 UTC
Previous Close
$0
Day Range
$0$0
Year Range
$0$0.05
Market Cap
220.51K
AVG Volume
263.11K
Trailing/Forward PE
-0/0
PEG ratio
-0
Dividend Yield
-
Next Earnings Date
2026-11-06
Primary Exchange
Other OTCUS
Revenue (USD) · TTM
020M40M60M80M21 Q121 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q2
SRNE Revenue (USD) · TTM by quarter
PeriodRevenue (USD) · TTM
23 Q264.27M
23 Q160.71M
22 Q462.84M
22 Q360.32M
22 Q254.98M
22 Q157.03M
21 Q452.9M
21 Q351.33M
21 Q251.02M
21 Q146.52M
Net Income (USD) · TTM
-800M-600M-400M-200M021 Q121 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q2
SRNE Net Income (USD) · TTM by quarter
PeriodNet Income (USD) · TTM
23 Q2-549.21M
23 Q1-673.54M
22 Q4-574.74M
22 Q3-495.47M
22 Q2-524.58M
22 Q1-471.65M
21 Q4-428.32M
21 Q3-355.41M
21 Q2-319.63M
21 Q1-230.75M
Operating Income (USD) · TTM
-600M-400M-200M021 Q121 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q2
SRNE Operating Income (USD) · TTM by quarter
PeriodOperating Income (USD) · TTM
23 Q2-463.35M
23 Q1-478M
22 Q4-478.53M
22 Q3-413.72M
22 Q2-393.84M
22 Q1-402.51M
21 Q4-380.53M
21 Q3-346.24M
21 Q2-339.08M
21 Q1-286.26M
EBITDA (USD) · TTM
-800M-600M-400M-200M021 Q121 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q2
SRNE EBITDA (USD) · TTM by quarter
PeriodEBITDA (USD) · TTM
23 Q2-527.87M
23 Q1-642.25M
22 Q4-536.93M
22 Q3-503.47M
22 Q2-528.5M
22 Q1-476.1M
21 Q4-436.77M
21 Q3-332.75M
21 Q2-301.69M
21 Q1-216.26M
Cash Flows (USD) · TTM
-400M-300M-200M-100M021 Q121 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q2
SRNE Cash Flows (USD) · TTM by quarter
PeriodCash Flows (USD) · TTM
23 Q2-243.21M
23 Q1-271.11M
22 Q4-307.51M
22 Q3-309M
22 Q2-328.28M
22 Q1-326.59M
21 Q4-290.69M
21 Q3-268.63M
21 Q2-252.13M
21 Q1-208.59M
EPS (USD) · TTM
-2-1.5-1-0.5021 Q121 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q2
SRNE EPS (USD) · TTM by quarter
PeriodEPS (USD) · TTM
23 Q2-1.14
23 Q1-1.52
22 Q4-1.38
22 Q3-1.34
22 Q2-1.54
22 Q1-1.56
21 Q4-1.43
21 Q3-1.24
21 Q2-1.17
21 Q1-0.96
Expenses (USD) · TTM
0200M400M600MR&DSG&ACapex21 Q121 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q2
SRNE Expenses (USD) · TTM by quarter
PeriodExpenses (USD) · TTM
23 Q2388.24M
23 Q1405.19M
22 Q4417.22M
22 Q3448.11M
22 Q2423.19M
22 Q1432.27M
21 Q4410.59M
21 Q3381.27M
21 Q2365.68M
21 Q1306.85M
Shares Outstanding (USD) · TTM
-100M-75M-50M-25M0Buybacks (Repurchases)Stock-Based Compensation21 Q121 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q2
SRNE Shares Outstanding (USD) · TTM by quarter
PeriodShares Outstanding (USD) · TTM
23 Q2-69.21M
23 Q1-72.34M
22 Q4-74.85M
22 Q3-80.3M
22 Q2-82.9M
22 Q1-87.32M
21 Q4-90.19M
21 Q3-85.62M
21 Q2-70.81M
21 Q1-51.4M
Employee Count
02505007501K2013201420152016201720182019202020212022
SRNE Employee Count by quarter
PeriodEmployee Count
2022949
2021799
2020502
2019310
2018382
2017162
2016154
201597
201466
201350
PE Ratio
0.580.590.590.6Apr 18May 18
SRNE PE Ratio by quarter
PeriodPE Ratio
May 180.6
Apr 180.59
Free Cash Flow Yield
-150000%-100000%-50000%0%med -30462.16%Jan 25May 25Sep 25Jan 26May 26Sep 26
SRNE Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-110294.02%
Sep 26-110294.02%
Sep 26-73529.35%
Aug 26-88235.22%
Aug 26-55147.01%
Aug 26-63025.16%
Aug 26-88235.22%
Jul 26-88235.22%
Jul 26-110294.02%
Jul 26-44117.61%
Jul 26-63025.16%
Jul 26-80213.84%
Jun 26-44117.61%
Jun 26-40106.92%
Jun 26-49019.57%
Jun 26-88235.22%
May 26-88235.22%
May 26-88235.22%
May 26-73529.35%
May 26-49019.57%
May 26-88235.22%
Apr 26-49019.57%
Apr 26-55147.01%
Apr 26-19181.57%
Apr 26-13786.75%
Mar 26-18382.34%
Mar 26-14231.49%
Mar 26-11609.9%
Mar 26-9191.17%
Feb 26-27573.51%
Feb 26-11609.9%
Feb 26-17647.04%
Feb 26-17647.04%
Jan 26-17647.04%
Jan 26-12605.03%
Jan 26-12605.03%
Jan 26-14231.49%
Jan 26-14005.59%
Dec 25-13786.75%
Dec 25-24509.78%
Dec 25-11312.21%
Dec 25-11923.68%
Nov 25-5584.51%
Nov 25-6787.32%
Nov 25-4901.96%
Nov 25-4901.96%
Oct 25-5656.1%
Oct 25-7352.93%
Oct 25-6302.52%
Oct 25-7352.93%
Oct 25-12605.03%
Sep 25-12605.03%
Sep 25-8823.52%
Sep 25-12605.03%
Sep 25-11923.68%
Aug 25-7352.93%
Aug 25-10259.91%
Aug 25-21008.39%
Aug 25-29411.74%
Aug 25-29411.74%
Jul 25-31512.58%
Jul 25-31512.58%
Jul 25-18382.34%
Jul 25-33936.62%
Jun 25-20053.46%
Jun 25-20053.46%
Jun 25-21008.39%
Jun 25-21008.39%
May 25-33936.62%
May 25-33936.62%
May 25-40106.92%
May 25-21008.39%
May 25-49019.57%
Apr 25-44117.61%
Apr 25-49019.57%
Apr 25-44117.61%
Apr 25-44117.61%
Mar 25-63025.16%
Mar 25-63025.16%
Mar 25-63025.16%
Mar 25-63025.16%
Feb 25-88235.22%
Feb 25-73529.35%
Feb 25-73529.35%
Feb 25-88235.22%
Jan 25-110294.02%
Jan 25-88235.22%
Jan 25-88235.22%
Jan 25-73529.35%
Jan 25-73529.35%
Dec 24-63025.16%
Dec 24-55147.01%
Dec 24-29411.74%
Dec 24-36764.67%
Nov 24-29411.74%
Nov 24-17647.04%
Nov 24-12605.03%
Nov 24-4411.76%
Nov 24-16339.86%
Oct 24-12254.89%
Price to Sales
00.030.050.080.1med 0.01Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
SRNE Price to Sales by quarter
PeriodPrice to Sales
Sep 260
Sep 260
Sep 260.01
Aug 260
Aug 260.01
Aug 260.01
Aug 260
Jul 260
Jul 260
Jul 260.01
Jul 260.01
Jul 260
Jun 260.01
Jun 260.01
Jun 260.01
Jun 260
May 260
May 260
May 260.01
May 260.01
May 260
Apr 260.01
Apr 260.01
Apr 260.02
Apr 260.03
Mar 260.02
Mar 260.03
Mar 260.03
Mar 260.04
Feb 260.01
Feb 260.03
Feb 260.02
Feb 260.02
Jan 260.02
Jan 260.03
Jan 260.03
Jan 260.03
Jan 260.03
Dec 250.03
Dec 250.02
Dec 250.03
Dec 250.03
Nov 250.07
Nov 250.06
Nov 250.08
Nov 250.08
Oct 250.07
Oct 250.05
Oct 250.06
Oct 250.05
Oct 250.03
Sep 250.03
Sep 250.04
Sep 250.03
Sep 250.03
Aug 250.05
Aug 250.04
Aug 250.02
Aug 250.01
Aug 250.01
Jul 250.01
Jul 250.01
Jul 250.02
Jul 250.01
Jun 250.02
Jun 250.02
Jun 250.02
Jun 250.02
May 250.01
May 250.01
May 250.01
May 250.02
May 250.01
Apr 250.01
Apr 250.01
Apr 250.01
Apr 250.01
Mar 250.01
Mar 250.01
Mar 250.01
Mar 250.01
Feb 250
Feb 250.01
Feb 250.01
Feb 250
Jan 250
Jan 250
Jan 250
Jan 250.01
Jan 250.01
Dec 240.01
Dec 240.01
Dec 240.01
Dec 240.01
Nov 240.01
Nov 240.02
Nov 240.03
Nov 240.09
Nov 240.02
Oct 240.03
EV/EBITDA
-20-15-10-50med -0.65Jan 16Nov 17Jan 18Apr 18Jun 18Aug 18Nov 18
SRNE EV/EBITDA by quarter
PeriodEV/EBITDA
Nov 18-7.2
Oct 18-7.35
Oct 18-7.29
Oct 18-7.23
Oct 18-7.12
Sep 18-7
Sep 18-7.03
Sep 18-7.02
Sep 18-6.84
Aug 18-6.68
Aug 18-6.66
Aug 18-6.73
Aug 18-6.72
Aug 18-0.74
Jul 18-0.73
Jul 18-0.69
Jul 18-0.64
Jul 18-0.65
Jun 18-0.64
Jun 18-0.67
Jun 18-0.63
Jun 18-0.62
Jun 18-0.61
May 18-0.61
May 18-0.64
May 18-0.62
May 18-0.39
Apr 18-0.39
Apr 18-0.14
Apr 18-0.15
Apr 18-0.15
Mar 18-0.16
Mar 18-0.13
Mar 18-0.12
Mar 18-0.12
Mar 18-0.13
Feb 18-0.1
Feb 18-0.1
Feb 18-0.13
Feb 18-0.12
Jan 18-0.12
Jan 18-0.14
Jan 18-0.16
Jan 18-0.16
Dec 17-0.18
Dec 17-0.18
Dec 17-0.19
Dec 17-0.2
Dec 17-0.2
Nov 17-0.2
Nov 17-0.2
Nov 17-0.19
Mar 16-19.01
Mar 16-18.99
Feb 16-18.98
Feb 16-19
Feb 16-19.03
Feb 16-19.06
Jan 16-19.05
Jan 16-18.99
Jan 16-19
Jan 16-18.93
Dec 15-18.83
Dec 15-18.78
Dec 15-18.88
Dec 15-18.9
Dec 15-18.88
Nov 15-18.85
Nov 15-18.89
Price to Book
00.050.10.150.2med 0.07Jun 21Sep 21Dec 21Apr 22Jul 22Nov 22Feb 23
SRNE Price to Book by quarter
PeriodPrice to Book
Feb 230.01
Feb 230.01
Feb 230.03
Feb 230.04
Jan 230.04
Jan 230.04
Jan 230.04
Jan 230.04
Dec 220.03
Dec 220.03
Dec 220.04
Dec 220.04
Dec 220.04
Nov 220.05
Nov 220.05
Nov 220.06
Nov 220.04
Oct 220.05
Oct 220.05
Oct 220.04
Oct 220.04
Sep 220.05
Sep 220.05
Sep 220.06
Sep 220.07
Sep 220.06
Aug 220.06
Aug 220.06
Aug 220.04
Aug 220.04
Jul 220.04
Jul 220.04
Jul 220.04
Jul 220.04
Jul 220.03
Jun 220.03
Jun 220.03
Jun 220.02
Jun 220.03
May 220.02
May 220.02
May 220.02
May 220.02
Apr 220.06
Apr 220.07
Apr 220.07
Apr 220.08
Apr 220.09
Mar 220.1
Mar 220.1
Mar 220.09
Mar 220.05
Feb 220.06
Feb 220.06
Feb 220.07
Feb 220.07
Jan 220.07
Jan 220.09
Jan 220.1
Jan 220.1
Dec 210.11
Dec 210.13
Dec 210.14
Dec 210.14
Dec 210.11
Nov 210.14
Nov 210.14
Nov 210.15
Nov 210.15
Oct 210.11
Oct 210.1
Oct 210.11
Oct 210.1
Oct 210.11
Sep 210.12
Sep 210.13
Sep 210.12
Sep 210.14
Aug 210.14
Aug 210.13
Aug 210.14
Aug 210.13
Jul 210.1
Jul 210.1
Jul 210.1
Jul 210.11
Jul 210.12
Jun 210.12
Jun 210.1
Jun 210.11
Jun 210.1
May 210.09
May 210.09
May 210.08
May 210.09
Apr 210.15
Apr 210.14
Apr 210.13
Apr 210.13
Apr 210.14
Sorrento Therapeutics, Inc.
SRNE
Stockpicker

Video analysis: SRNE

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.